12 August 2023 : Clinical Research
Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson's Disease Treatment
Yusuke Nomoto1ABCDEF*, Makoto Furihata1ABCDEF, Haruka Hagiwara1F, Hirotaka Ishino1B, Shintaro Yano1D, Hiroki Okawa1B, Yoichi Nakatsu1B, Kumiko Noda1B, Shinjiro Nishi1F, Shingo Ogiwara1AB, Tsuneo Kitamura1D, Taro Osada1AGDOI: 10.12659/MSM.941285
Med Sci Monit 2023; 29:e941285
Table 6 Outcomes of PEG-J procedures.
General outcomes of PEG-J procedures | |
---|---|
Procedure time | 21.7±12.5 (range: 8–51) min. |
Hospital stay | 27.8±15.8 (range: 13–98) days |
Successful rate | 100.0% (n=44/44 procedures) |
Mortality rate | 0.0% (n=0/44 procedures) |
Dropout rate (LCIG) | 16.3% (n=7/43 patients) |
Observation period | 19 (median) (range: 3–40) months |
Procedure-related AEs | 15.9% |
Device-related AEs | 60.5% |
PEG-J – percutaneous endoscopic transgastric jejunostomy; LCIG – levodopa-carbidopa intestinal gel; AE – adverse events. Data are presented as mean±standard deviation. |